Author

L. Verset

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Boisson· 1 shared A. Hadefi· 1 shared A. Lefort· 1 shared C. Bouchart· 1 shared C. Liefferinckx· 1 shared C. Moreno· 1 shared D. Jacques· 1 shared D. Monteyne· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Boisson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Duodenal organoids from metabolic dysfunction-associated steatohepatitis patients exhibit altered digestive homeostasis

A. Hadefi, M. Leprovots, G. Dinsart, M. Marefati, M. Vermeersch, D. Monteyne, D. Perez-Morga, A. Lefort, F. Libert, L. Verset, C. Liefferinckx, C. Moreno, D. Jacques, E. Trepo, M.-I. Garcia

This study examines duodenal organoids from MASH patients and finds altered digestive homeostasis and junctional protein misexpression without barrier dysfunction.

bioRxiv · Jul 2, 2024 · PreprintCell Biology

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy

C. Bouchart, O. A. Senar, J. Navez, L. Verset, A. Boisson, M. Hein, K. Stosic, E. Quertinmont, V. Tafciu, S. Zhao, L. Mas, N. D'Haene, D. Van Gestel, L. Moretti, I. Rooman, , J.-L. Van Laethem

This study shows that combining FOLFIRINOX with stereotactic body radiotherapy remodels pancreatic ductal adenocarcinoma, improving stromal and metabolic features and prognosis.

bioRxiv · Apr 30, 2024 · PreprintCancer Biology